Handling of computational in vitro/in vivo correlation problems by Microsoft Excel II. Distribution functions and moments

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 55, Issue 1, 2003, Pages 77-84

  Langenbucher, Frieder ^a  

^a BioVista LLC   (Switzerland)

Author keywords

Cumulative distribution function; Curve fitting; Distribution functions; Excel; Extent; In vitro in vivo correlation; Moments; Polyexponential; Probability density function; Rate; Weibull

Indexed keywords

BACLOFEN; BENAZEPRIL; CADRALAZINE; CARBAMAZEPINE; DICLOFENAC; DILTIAZEM; FELODIPINE; FORMOTEROL; METOPROLOL; OXCARBAZEPINE; OXPRENOLOL; PHENYLBUTAZONE; PIRPROFEN; PROPYPHENAZONE;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CORRELATION ANALYSIS; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL COMPUTING; PARAMETER; PLASMA; STATISTICS; URINARY EXCRETION;

EID: 0037237894     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(02)00115-7     Document Type: Article

References (14)

1. Langenbucher F. Handling of computational in vitro/in vivo correlation problems by Microsoft Excel. Eur. J. Pharm. Biopharm. 53:2002;1-7.
2. Sathe P., Tsong Y., Shah V.P. In vitro dissolution profile comparison and IVIVR, carbamazepine case. Young D., Devane J.G., Butler J. In vitro-in vivo correlations. 1997;31-42 Plenum Press, New York, NY.
3. Johnson N.L., Leone F.C. Statistics and Experimental Design in Engineering and the Physical Sciences. 1977;Wiley, New York, NY.
4. Bennett C.A., Franklin N.L. Statistical Analysis in Chemistry and the Chemical Industry. 1963;Wiley, New York, NY.
5. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol. 24:1972;979-981.
6. Langenbucher F. Parametric representation of dissolution rate curves by the RRSBW distribution. Pharm. Ind. 38:1976;472-477.
7. Kotz S., Johnson N.L. Encyclopedia of Statistical Sciences. 1988;Wiley, New York, NY. pp. 549-556.
8. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J. Pharmacokin. Biopharm. 6:1978;547-558.
9. Cutler D.J. Theory of the mean absorption time, an adjunct to conventional bioavailability studies. J. Pharm. Pharmacol. 30:1978;476-478.
10. Brockmeier D. In vitro/in vivo correlation of dissolution using moments of disssolution and transit times. Acta Pharm. Technol. 32:1986;164-174.
11. Beal S.L. Some clarifications regarding moment of residence times with pharmacokinetic models. J. Pharmacokin. Biopharm. 15:1987;75-92.
12. Brockmeier D. Mean time concept and component analysis in pharmacokinetics. Int. J. Clin. Pharmacol. Ther. 37:1999;555-561.
13. Shargel L., Yu A.B.C. Applied Biopharmaceutics and Pharmacokinetics. 1999;Appleton & Lange, Stamford, CT.
14. Edgar B., Lundborg P., Regardh C.G. Clinical Pharmacokinetics of Felodipine. Drugs. 34:(Suppl. 3):1987;16-27.